Insider · CIK 0002073587
Tyler Herb
officer
Files at FIG (Figma, Inc.). First filing Nov 5, 2025, latest Oct 7, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 7
$0 bought, $2.3M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
FIG: Figma, Inc.
FIGOct 9, 2026 · close 22.50
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 8Weak | Figma, Inc. | $31k 1,418 shares | -1% | +31% from low-69% from high | |
| 9Weak | Figma, Inc. | $37k 1,416 shares | -1% | - | |
| 19Weak | Figma, Inc. | $85k 2,310 shares | -1% | +11% from low-69% from high | |
| 40Moderate | Figma, Inc. | $109k 3,073 shares | -1% | +6% from low-71% from high | |
| 15Weak | Figma, Inc. | $29k 757 shares | -0% | 0% from low-69% from high | |
| 25Weak | Figma, Inc. | $1.9M 43,357 shares | -17% | +1% from low-64% from high | |
| 41Moderate | Figma, Inc. | $151k 3,133 shares | -1% | 0% from low-61% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | FIG Figma, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,418 | $21.63 | $31k | 246,130 | 5 d ago |
| Oct 1, 2026 | FIG Figma, Inc. | FTax withholding Class A Common Stock | -1,838 | $21.02 | $39k | 247,548 | 7 d ago |
| Sep 3, 2026 | FIG Figma, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,416 | $26.29 | $37k | 249,386 | 34 d ago |
| Sep 1, 2026 | FIG Figma, Inc. | FTax withholding Class A Common Stock | -1,838 | $27.49 | $51k | 250,802 | 39 d ago |
| Dec 3, 2025 | FIG Figma, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,200 | $36.10 | $43k | 204,516 | Dec 5, 2025 |
| Dec 3, 2025 | FIG Figma, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,110 | $37.14 | $41k | 203,406 | Dec 5, 2025 |
| Dec 1, 2025 | FIG Figma, Inc. | SOpen-market sale Class A Common Stock | -3,073 | $35.45 | $109k | 205,716 | Dec 3, 2025 |
| Nov 17, 2025 | FIG Figma, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -757 | $38.21 | $29k | 208,789 | Nov 19, 2025 |
| Nov 10, 2025 | FIG Figma, Inc. | MOption exercise Class A Common Stock10b5-1 | +26,059 | $23.19 | $604k | 252,146 | Nov 13, 2025 |
| Nov 10, 2025 | FIG Figma, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -12,577 | $42.97 | $540k | 239,569 | Nov 13, 2025 |
| Nov 10, 2025 | FIG Figma, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -11,887 | $43.75 | $520k | 227,682 | Nov 13, 2025 |
| Nov 10, 2025 | FIG Figma, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -18,893 | $44.69 | $844k | 208,789 | Nov 13, 2025 |
| Nov 10, 2025 | FIG Figma, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -26,059 | $0.00 | $0 | 4,311 | Nov 13, 2025 |
| Nov 3, 2025 | FIG Figma, Inc. | SOpen-market sale Class A Common Stock | -3,133 | $48.17 | $151k | 226,087 | Nov 5, 2025 |
| Oct 1, 2025 | FIG Figma, Inc. | FTax withholding Class A Common Stock | -3,028 | $51.87 | $157k | 229,220 | Oct 3, 2025 |
| Sep 1, 2025 | FIG Figma, Inc. | FTax withholding Class A Common Stock | -3,029 | $70.28 | $213k | 232,248 | Sep 3, 2025 |
| Aug 1, 2025 | FIG Figma, Inc. | FTax withholding Class A Common Stock | -3,028 | $115.50 | $350k | 235,277 | Aug 5, 2025 |
| Jul 30, 2025 | FIG Figma, Inc. | FTax withholding Class A Common Stock | -35,256 | $33.00 | $1.2M | 238,305 | Aug 1, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.